| Year |
Citation |
Score |
| 2011 |
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. European Journal of Pharmacology. 667: 80-90. PMID 21651903 DOI: 10.1016/J.Ejphar.2011.05.054 |
0.434 |
|
| 2003 |
Donevan SD, White HS, Anderson GD, Rho JM. Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate. Epilepsia. 44: 1274-9. PMID 14510820 DOI: 10.1046/J.1528-1157.2003.07203.X |
0.709 |
|
| 2003 |
Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system. Journal of Child Neurology. 18: 39-48; discussion 49. PMID 12661937 DOI: 10.1177/08830738030180012101 |
0.653 |
|
| 2002 |
Jimenez EC, Donevan S, Walker C, Zhou LM, Nielsen J, Cruz LJ, Armstrong H, White HS, Olivera BM. Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Research. 51: 73-80. PMID 12350383 DOI: 10.1016/S0920-1211(02)00101-8 |
0.388 |
|
| 2002 |
Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia. 43: 358-61. PMID 11952765 DOI: 10.1046/J.1528-1157.2002.47901.X |
0.486 |
|
| 2000 |
Donevan SD, McCabe RT. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Molecular Pharmacology. 58: 614-23. PMID 10953056 |
0.514 |
|
| 2000 |
Ravindranathan A, Donevan SD, Sugden SG, Greig A, Rao MS, Parks TN. Contrasting molecular composition and channel properties of AMPA receptors on chick auditory and brainstem motor neurons. The Journal of Physiology. 523: 667-84. PMID 10718746 DOI: 10.1111/J.1469-7793.2000.00667.X |
0.408 |
|
| 2000 |
Greig A, Donevan SD, Mujtaba TJ, Parks TN, Rao MS. Characterization of the AMPA-activated receptors present on motoneurons. Journal of Neurochemistry. 74: 179-91. PMID 10617119 DOI: 10.1046/j.1471-4159.2000.0740179.x |
0.341 |
|
| 2000 |
White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. The Journal of Pharmacology and Experimental Therapeutics. 292: 425-32. PMID 10604979 |
0.449 |
|
| 1999 |
Rogawski MA, Donevan SD. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Advances in Neurology. 79: 947-63. PMID 10514878 |
0.672 |
|
| 1999 |
Twyman RE, Rogers SW, Gahring LC, Carlson NG, Donevan SD. Antibodies to glutamate receptors: a role in excitatory dysregulation of the central nervous system? Advances in Neurology. 79: 535-41. PMID 10514841 |
0.37 |
|
| 1999 |
Donevan S. Subtype selective NMDA antagonists for the treatment of neurological disease Cns Drug Reviews. 5: 10. |
0.321 |
|
| 1998 |
Donevan SD, Rogawski MA. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Neuroscience. 87: 615-29. PMID 9758228 DOI: 10.1016/S0306-4522(98)00109-2 |
0.734 |
|
| 1998 |
Donevan SD, Beg A, Gunther JM, Twyman RE. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors. The Journal of Pharmacology and Experimental Therapeutics. 285: 539-45. PMID 9580595 |
0.498 |
|
| 1997 |
Rho JM, Donevan SD, Rogawski MA. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. The Journal of Pharmacology and Experimental Therapeutics. 280: 1383-91. PMID 9067327 |
0.733 |
|
| 1996 |
Rho JM, Donevan SD, Rogawski MA. Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. The Journal of Physiology. 497: 509-22. PMID 8961191 DOI: 10.1113/Jphysiol.1996.Sp021784 |
0.714 |
|
| 1996 |
Donevan SD, Rogawski MA. Multiple actions of arylalkylamine arthropod toxins on the N-methyl-D-aspartate receptor. Neuroscience. 70: 361-75. PMID 8848146 DOI: 10.1016/0306-4522(95)00342-8 |
0.71 |
|
| 1996 |
Chen K, Kokate TG, Donevan SD, Carroll FI, Rogawski MA. Ibogaine block of the NMDA receptor: in vitro and in vivo studies. Neuropharmacology. 35: 423-31. PMID 8793904 DOI: 10.1016/0028-3908(96)84107-4 |
0.753 |
|
| 1996 |
Subramaniam S, Donevan SD, Rogawski MA. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 276: 161-8. PMID 8558426 |
0.713 |
|
| 1996 |
Rho JM, Donevan SD, Rogawski MA. Direct activation of GABA(A) receptors by barbiturates in cultured rat hippocampal neurons Journal of Physiology. 497: 509-522. |
0.686 |
|
| 1995 |
Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA. Felbamate block of the N-methyl-D-aspartate receptor. The Journal of Pharmacology and Experimental Therapeutics. 273: 878-86. PMID 7752093 |
0.766 |
|
| 1995 |
Donevan SD, Rogawski MA. Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proceedings of the National Academy of Sciences of the United States of America. 92: 9298-302. PMID 7568121 DOI: 10.1073/Pnas.92.20.9298 |
0.685 |
|
| 1994 |
Subramaniam S, Donevan SD, Rogawski MA. Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites. Molecular Pharmacology. 45: 117-24. PMID 8302270 |
0.624 |
|
| 1994 |
Rho JM, Donevan SD, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors. Annals of Neurology. 35: 229-34. PMID 8109904 DOI: 10.1002/ana.410350216 |
0.766 |
|
| 1994 |
Sofia RD, Rho JM, Donevan SD, Subramaniam S, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: Opposing effects on N-methyl-D-aspartate and γ-aminobutyric acid(A) receptors [1] Annals of Neurology. 36: 677-678. PMID 7944305 |
0.712 |
|
| 1994 |
Donevan SD, Yamaguchi S, Rogawski MA. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. The Journal of Pharmacology and Experimental Therapeutics. 271: 25-9. PMID 7525924 |
0.652 |
|
| 1993 |
Yamaguchi S, Donevan SD, Rogawski MA. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Research. 15: 179-84. PMID 7693450 DOI: 10.1016/0920-1211(93)90054-B |
0.59 |
|
| 1993 |
Donevan SD, Rogawski MA. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10: 51-9. PMID 7678966 DOI: 10.1016/0896-6273(93)90241-I |
0.757 |
|
| 1992 |
Donevan SD, Jones SM, Rogawski MA. Arcaine blocks N-methyl-D-aspartate receptor responses by an open channel mechanism: whole-cell and single-channel recording studies in cultured hippocampal neurons. Molecular Pharmacology. 41: 727-35. PMID 1373801 |
0.7 |
|
| 1992 |
Subramaniam S, Donevan SD, Rogawski MA. 1,10-Diaminodecane and 1,12-diaminododecane block NMDA receptor currents by an open channel mechanism. Neuroscience Letters. 147: 213-6. PMID 1283458 DOI: 10.1016/0304-3940(92)90598-2 |
0.698 |
|
| Show low-probability matches. |